Tumor imaging by means of proteolytic activation of cell-penetrating peptides.
暂无分享,去创建一个
Roger Y Tsien | R. Tsien | T. Jiang | M. Roy | P. Jennings | E. Olson | Q. Nguyen | Melinda Roy | Quyen T Nguyen | Patricia A Jennings | Emilia S Olson | Tao Jiang | Tao Jiang
[1] D. Piwnica-Worms,et al. Characterization of novel histidine-tagged Tat-peptide complexes dual-labeled with (99m)Tc-tricarbonyl and fluorescein for scintigraphy and fluorescence microscopy. , 2002, Bioconjugate chemistry.
[2] J. Rothbard,et al. Guanidinium rich peptide transporters and drug delivery. , 2003, Current protein & peptide science.
[3] Ruth Etzioni,et al. Early detection: The case for early detection , 2003, Nature Reviews Cancer.
[4] T. Turpeenniemi‐Hujanen,et al. Matrix metalloproteinase-2 (MMP-2) is associated with survival in breast carcinoma , 2003, British Journal of Cancer.
[5] Priscille Brodin,et al. A Truncated HIV-1 Tat Protein Basic Domain Rapidly Translocates through the Plasma Membrane and Accumulates in the Cell Nucleus* , 1997, The Journal of Biological Chemistry.
[6] C. Morris,et al. Brain matrix metalloproteinase 1 levels are elevated in Alzheimer's disease , 2000, Neuroscience Letters.
[7] L. Fink,et al. Cancer : a problem of developmental biology , 1978 .
[8] Y. Ikada,et al. Distribution and tissue uptake of poly(ethylene glycol) with different molecular weights after intravenous administration to mice. , 1994, Journal of pharmaceutical sciences.
[9] M. Johansson,et al. Cell surface adherence and endocytosis of protein transduction domains. , 2003, Molecular therapy : the journal of the American Society of Gene Therapy.
[10] Sabrina S Wilson. Radiology , 1938, Glasgow Medical Journal.
[11] Ralph Weissleder,et al. Differential conjugation of tat peptide to superparamagnetic nanoparticles and its effect on cellular uptake. , 2002, Bioconjugate chemistry.
[12] D. Piwnica-Worms,et al. Novel Tat-peptide chelates for direct transduction of technetium-99m and rhenium into human cells for imaging and radiotherapy. , 2000, Bioconjugate chemistry.
[13] A. Strongin,et al. Gelatin Zymography and Substrate Cleavage Assays of Matrix Metalloproteinase-2 in Breast Carcinoma Cells Overexpressing Membrane Type-1 Matrix Metalloproteinase , 2002, Laboratory Investigation.
[14] R. Visse,et al. Matrix Metalloproteinases Regulation and Dysregulation in the Failing Heart , 2002 .
[15] D. Piwnica-Worms,et al. Quantitative analysis of permeation peptide complexes labeled with Technetium-99m: chiral and sequence-specific effects on net cell uptake. , 2003, Bioconjugate chemistry.
[16] R. Gagescu. Cell division: Location, location, location , 2001, Nature Reviews Molecular Cell Biology.
[17] Eric Vives,et al. Cell-penetrating Peptides , 2003, The Journal of Biological Chemistry.
[18] K. Pattabiraman,et al. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[19] V. Raman,et al. Real time non‐invasive imaging of receptor–ligand interactions in vivo , 2003, Journal of cellular biochemistry.
[20] Z. Werb,et al. New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.
[21] V. Torchilin,et al. TAT-liposomes: a novel intracellular drug carrier. , 2003, Current protein & peptide science.
[22] Steven F Dowdy,et al. Transducible TAT-HA fusogenic peptide enhances escape of TAT-fusion proteins after lipid raft macropinocytosis , 2004, Nature Medicine.
[23] Ralph Weissleder,et al. Protease sensors for bioimaging , 2003, Analytical and bioanalytical chemistry.
[24] B. L. Wylie,et al. Arginine-rich molecular transporters for drug delivery: role of backbone spacing in cellular uptake. , 2002, Journal of medicinal chemistry.
[25] R. Duncan. The dawning era of polymer therapeutics , 2003, Nature Reviews Drug Discovery.
[26] R Weissleder,et al. Optical imaging of matrix metalloproteinase-2 activity in tumors: feasibility study in a mouse model. , 2001, Radiology.
[27] B. Franc,et al. Breaching biological barriers: protein translocation domains as tools for molecular imaging and therapy. , 2003, Molecular imaging.
[28] I. Pucci‐Minafra,et al. Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera , 2004, British Journal of Cancer.
[29] J. Frangioni,et al. An Operational Near-Infrared Fluorescence Imaging System Prototype for Large Animal Surgery , 2003, Technology in cancer research & treatment.
[30] Sanjiv S Gambhir,et al. 124I-labeled engineered anti-CEA minibodies and diabodies allow high-contrast, antigen-specific small-animal PET imaging of xenografts in athymic mice. , 2003, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[31] Ralph Weissleder,et al. In vivo molecular target assessment of matrix metalloproteinase inhibition , 2001, Nature Medicine.
[32] M. Duffy,et al. The ADAMs family of proteins: from basic studies to potential clinical applications , 2003, Thrombosis and Haemostasis.
[33] S. Gellman,et al. Cytoplasmic and Nuclear Delivery of a TAT-derived Peptide and a β-Peptide after Endocytic Uptake into HeLa Cells* , 2003, Journal of Biological Chemistry.
[34] M. Harris. Monoclonal antibodies as therapeutic agents for cancer. , 2004, The Lancet. Oncology.
[35] Ralph Weissleder,et al. Catheter-based in vivo imaging of enzyme activity and gene expression: feasibility study in mice. , 2004, Radiology.
[36] Jinha M. Park,et al. Characterization of engineered anti-p185HER-2 (scFv-CH3)2 antibody fragments (minibodies) for tumor targeting. , 2004, Protein engineering, design & selection : PEDS.
[37] R. Weissleder,et al. Fluorescence molecular tomography resolves protease activity in vivo , 2002, Nature Medicine.
[38] B. Nordén,et al. Uptake of analogs of penetratin, Tat(48-60) and oligoarginine in live cells. , 2003, Biochemical and biophysical research communications.
[39] J. Foidart,et al. Membrane type-1 matrix metalloproteinase and TIMP-2 in tumor angiogenesis. , 2003, Matrix biology : journal of the International Society for Matrix Biology.
[40] S. Rosewicz,et al. Differential expression of matrix metalloproteinases and their tissue inhibitors in colon mucosa of patients with inflammatory bowel disease , 2000, Gut.
[41] Ralph Weissleder,et al. Tat peptide-derivatized magnetic nanoparticles allow in vivo tracking and recovery of progenitor cells , 2000, Nature Biotechnology.